JPRN-UMIN000007710
Completed
未知
Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants - Study about live vaccines in children receiving immunosuppressants
Department of Nephrology and Rheumatology National Center for Child Health and Development0 sites200 target enrollmentApril 13, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)
- Sponsor
- Department of Nephrology and Rheumatology National Center for Child Health and Development
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Steroid use of more than 1mg/kg/d. 2\. For renal transplant recipients, \<1 year since transplantation or acute rejection within the previous 6 months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
assess the immunization compliance, common health problems of immunized under five children and perceived maternal barriers for immunization.CTRI/2017/07/009130I310
Recruiting
Not Applicable
Prospective study to evaluate trained immunity in kidney transplantationiertransplantatiegraft survivalkidney transplantationNL-OMON53183Radboud Universitair Medisch Centrum100
Active, not recruiting
Phase 1
A Study of Safety and Clinical Activity of Cancer Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsPatients with unresectable and progressive metastatic cutaneous melanoma, whose tumor expresses MAGE-A3.MedDRA version: 16.0Level: LLTClassification code 10027481Term: Metastatic melanomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2008-001918-25-BEGlaxoSmithKline Biologicals40
Active, not recruiting
Phase 1
A Study of Safety and Clinical Activity of Cancer Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsEUCTR2008-001918-25-FRGlaxoSmithKline Biologicals48
Completed
Phase 4
Influenza Specific Immunity After Vaccination in Recipients of Haematopoietic Stem Cell Transplantation Compared to Healthy ControlsHaematopoietic Stem Cell Transplant patientscancerhaematological malignancyAutologous or allogeneicInfluenzaCancer - Any cancerInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12614000240640Princess Margaret Hospital for children150